Publisher's Synopsis
The third volume in this major cancer series explores the role of the initial diagnostic and staging investigations currently used in the treatment of gynaecological cancer, and their influence on subsequent therapy. The book is mainly intended for the treating clinician who does not have ready access to the diverse literature on such subjects as tumour markers, hormone receptors, cytogenetics, and tumour cloning, and the role of these techniques in the assessment of clinical response to therapy, and in the long-term control of gynaecological cancer.
